Interval debulking surgery is not worth the wait: a National Cancer Database study comparing primary cytoreductive surgery versus neoadjuvant chemotherapy

OBJECTIVE: In previous studies, neoadjuvant chemotherapy followed by interval debulking surgery was not inferior to primary cytoreductive surgery as initial treatment for advanced epithelial ovarian cancer. Our study aimed to compare surgical and survival outcomes between the two treatments in a lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyons, Yasmin A, Reyes, Henry D, McDonald, Megan E, Newtson, Andreea, Devor, Eric, Bender, David P, Goodheart, Michael J, Gonzalez Bosquet, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362882/
https://www.ncbi.nlm.nih.gov/pubmed/32341114
http://dx.doi.org/10.1136/ijgc-2019-001124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362882/
https://www.ncbi.nlm.nih.gov/pubmed/32341114
http://dx.doi.org/10.1136/ijgc-2019-001124

Ejemplares similares